PDF] BCDB ‐ A database for breast cancer research and information

PDF) Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases

Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression, BMC Cancer

Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression, BMC Cancer

Association of tumor immune microenvironment profiling and 21-gene recurrence assay in early breast cancer patients, European Journal of Medical Research

Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer, BMC Cancer

Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer - The Breast

Information Support Provided by Specialized Nurses via Mobile Healthcare App May Improve Treatment Adherence of Breast Cancer Patients: An Observational Study - ScienceDirect

Ki67 increase after core needle biopsy associated with worse disease outcome in HER2-negative breast cancer patients

GABC: A comprehensive resource and Genome Atlas for Breast Cancer - Zhang - 2021 - International Journal of Cancer - Wiley Online Library

Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China

Frontiers Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma in situ